Occupational Therapists in Livingston, MT Accepting Medicare

9 Occupational Therapists found. Showing 1 - 9

Lindsey Lesley Anderson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672    Fax: 406-222-1406

Carrie Brewster, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 Robin Ln, Livingston, MT 59047 Phone: 406-222-7231    Fax: 406-222-2435

Melissa Yoakam Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 Robin Ln, Livingston, MT 59047 Phone: 406-222-7231

Tori Simpson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-222-3541

Beverly Waldeisen, OTR/C Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 601 Robin Ln, Livingston, MT 59047 Phone: 406-222-7231    Fax: 406-222-2435

Kelli Ann Turner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 408-222-7231

Emma Taylor Neal, MS OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 608 E Milky Way Dr, Livingston, MT 59047 Phone: 716-479-6708    Fax: 406-792-8016

Dana Allen, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 Robin Ln, Livingston, MT 59047 Phone: 406-220-1421

Cynthia Joline Ibes, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672    Fax: 406-222-1406

News Archive

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.

Study examines role of low-oxygen exposure in heart failure patients

Distance runners who live at high altitudes with low oxygen levels are known to improve their performance during races in areas that are at sea level. Can heart failure patients, who suffer from fatigue, improve their exercise performance by staying in a tent-like, high-altitude simulator?

Breakthrough could help protect against the use of smallpox by terrorists

Researchers at the ANU John Curtin School of Medical Research have identified proteins that determine which mice succumb to mousepox and which do not. The new insights into the immune response of mice to the mousepox virus could enable scientists to improve treatment for poxvirus infections, including smallpox.

Altheus Therapeutics initiates enrollment in Zoenasa Phase 2 study for ulcerative colitis

Altheus Therapeutics announced today it has randomized its first patient in a comparator-controlled Phase 2 efficacy study of Zoenasa, a novel combination therapy for ulcerative colitis (UC).

Opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant

Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.

Read more Medical News

› Verified 1 days ago